CVS Health Management
Management criteria checks 2/4
CVS Health's CEO is J. Joyner, appointed in Oct 2024, has a tenure of less than a year. directly owns 0.003% of the company’s shares, worth $2.68M. The average tenure of the management team and the board of directors is 2 years and 7 years respectively.
Key information
J. Joyner
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | 0.003% |
| Management average tenure | 2yrs |
| Board average tenure | 7yrs |
Recent management updates
Recent updates
Market Might Still Lack Some Conviction On CVS Health Corporation (NYSE:CVS) Even After 25% Share Price Boost
Feb 17
Earnings Beat: CVS Health Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Feb 14CVS Health Jumps On Q4 Earnings Beat, But Downgrading To Hold
Feb 13CVS Health Isn't Going To The Dogs
Jan 17CVS Health: An Attractive 5.8% Safe Yield For Now
Jan 10Market Cool On CVS Health Corporation's (NYSE:CVS) Earnings Pushing Shares 25% Lower
Dec 26CVS Health: When The Industry Is In Crisis, Don't Pick The Weaker Players
Dec 10There May Be Some Bright Spots In CVS Health's (NYSE:CVS) Earnings
Nov 19CVS Health: Cheap But No Signs Of Turnaround (Yet)
Nov 06CVS Health (NYSE:CVS) Has A Somewhat Strained Balance Sheet
Nov 03CVS Health Stock Dip: Undervalued And Ready For A Turnaround
Oct 24CVS Health: Glenview's Activism Ramps Up Pressure On Management
Sep 30CVS Health: At Least There's A Valuable Lesson (Rating Downgrade)
Sep 10A Piece Of The Puzzle Missing From CVS Health Corporation's (NYSE:CVS) Share Price
Aug 08CVS Health Q2 Earnings: CEO's Swinging Axe May Have Ended The Bear Run
Aug 07Here's Why CVS Health (NYSE:CVS) Has A Meaningful Debt Burden
Jul 21CVS Health: A Better Investment Than Walgreens Boots Alliance
Jul 09Vltava Fund - CVS Health Corp.: Why We Sold CVS
Jul 03CVS Health: Mismanagement, Eroding Moat And Poor Momentum Make It A Sell
Jun 21The Correct Play On CVS Health
Jun 06CVS Health: Downside Movement Is Overdramatic
May 26CVS Health: Secure Dividend And Upside Potential Presents Compelling Opportunity
May 15We Think Shareholders Are Less Likely To Approve A Pay Rise For CVS Health Corporation's (NYSE:CVS) CEO For Now
May 10CVS Health: A Terrible Earnings Report, But An Undervalued Stock
May 04CVS Health Corporation Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
May 03CVS Health: 8x P/E, 8% Growth Projection - It's A Market Blind Spot
Apr 22Sentiment Still Eluding CVS Health Corporation (NYSE:CVS)
Apr 14CEO
J. Joyner (59 yo)
less than a year
Tenure
Mr. J. David Joyner is President, CEO & Director of CVS Health Corporation from October 17, 2024 and served as Executive Vice President from January 30, 2023 to October 17, 2024 and was President of CVS Ca...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman of the Board | 6.3yrs | US$576.50k | 0.00033% $ 273.9k | |
| Executive VP & CFO | 1.3yrs | US$4.58m | 0.0028% $ 2.3m | |
| Executive VP of Ventures and Chief Digital | 2.6yrs | US$8.88m | 0.0032% $ 2.7m | |
| Executive VP | 2yrs | US$11.89m | 0.00077% $ 639.1k | |
| Executive VP & Group President | 3.3yrs | US$8.58m | 0.0038% $ 3.1m | |
| President | less than a year | no data | 0.0032% $ 2.7m | |
| Senior Director of Business Development & CVS Health and Partner & Co-Founder | no data | no data | no data | |
| Senior VP | 6.3yrs | no data | 0.00067% $ 556.1k | |
| Executive VP & Chief Compliance Officer | no data | no data | no data | |
| Executive VP & Chief People Officer | less than a year | no data | no data | |
| Head of Markets of Healthcare Benefits | 3yrs | no data | no data | |
| Chief Sustainability Officer & Senior VP of Corporate Social Responsibility | 2yrs | no data | no data |
2.0yrs
Average Tenure
57yo
Average Age
Experienced Management: CVS's management team is considered experienced (2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman of the Board | 6.3yrs | US$576.50k | 0.00033% $ 273.9k | |
| President | less than a year | no data | 0.0032% $ 2.7m | |
| Independent Director | 1.3yrs | US$195.42k | 0.00068% $ 564.4k | |
| Independent Director | 7.8yrs | US$301.50k | 0.00094% $ 780.2k | |
| Independent Director | 11.4yrs | US$321.50k | 0.0027% $ 2.3m | |
| Independent Director | 14.1yrs | US$321.50k | 0.0024% $ 2.0m | |
| Independent Director | 17.9yrs | US$321.50k | 0.0098% $ 8.2m | |
| Independent Director | 17.9yrs | US$321.50k | 0.0089% $ 7.4m | |
| Independent Director | 9.9yrs | US$301.50k | 0.00024% $ 199.2k | |
| Independent Director | 6.3yrs | US$318.17k | 0.0030% $ 2.5m | |
| Independent Director | 2.4yrs | US$301.50k | 0.00077% $ 639.1k | |
| Independent Director | 1.3yrs | US$167.50k | 0.0013% $ 1.0m |
7.0yrs
Average Tenure
67yo
Average Age
Experienced Board: CVS's board of directors are considered experienced (7 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/18 02:37 |
| End of Day Share Price | 2025/02/18 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
CVS Health Corporation is covered by 60 analysts. 24 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Harshit Gupta | Accountability Research Corporation |
| Christopher Graja | Argus Research Company |
| Samuel Hudson | Atlantic Equities LLP |